Le Lézard
Classified in: Business
Subject: PER

Crayhill Capital Management Names Shamafa Khan as Head of Investor Relations as Firm Expands Private Structured Credit Platform


NEW YORK, Oct. 16, 2017 /PRNewswire/ -- Crayhill Capital Management, an alternative asset management firm focused on private structured credit, announced today the appointment of Shamafa Khan as a Managing Director and Head of Investor Relations and Marketing.

At Crayhill, Ms. Khan will leverage her previous experience in capital raising and client relationships to help serve the firm's investors. Specifically, she will be leading the marketing and sales efforts of Crayhill's private asset-based lending and credit opportunity funds.

"Private credit funds continue to gain attention from investors seeking stable current-yield returns. Shamafa's recent experience within the sector will help us to highlight our differentiated approach and better serve our limited partners," said Josh Eaton, Co-Founder and Managing Partner at Crayhill.

"Shamafa will be instrumental in bolstering our efforts to expand Crayhill's leadership in the private structured credit space. Her keen understanding of our investment approach and the risk/reward balance we aim to achieve for our investors makes her well suited to represent the firm and communicate our value proposition," added Carlos Mendez, Co-Founder and Managing Partner at Crayhill. 

Ms. Khan brings over 13 years of alternative investment expertise to Crayhill. She most recently worked as a Director in the Global Business Development Group of Barings, LLC (formerly Babson Capital), where she was responsible for capital raising and client relationships for a suite of fixed income strategies. Previously, she served as an Associate Director in UBS's Capital Introduction Group, where she advised hedge fund clients and institutional investors on capital raising and investment efforts. Ms. Khan is a graduate of Columbia University with a bachelor's degree in Industrial Engineering & Operations Research and a minor in Economics.

About Crayhill Capital Management
Crayhill Capital Management LP is a New York based alternative asset management firm that specializes in asset-based, private structured credit investments. Crayhill provides tailored capital solutions to experienced and growing specialty finance companies and other asset-heavy platforms that do not have ready access to funding through traditional channels. The Crayhill investment team has decades of experience sourcing, underwriting, structuring, financing and monetizing complex investment opportunities. Crayhill was launched in August 2015 and is registered with the U.S. SEC as an investment adviser. For more information please visit www.crayhill.com.

CONTACT: 
Shree Dhond
Dukas Linden Public Relations
(646) 722-6531
[email protected]
[email protected]

SOURCE Crayhill Capital Management


These press releases may also interest you

at 22:45
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against SSR Mining...

at 22:45
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Shoals...

at 22:10
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lincoln National Corporation ("Lincoln National" or "the Company") and certain of its...

at 21:29
TSX VENTURE COMPANIES BULLETIN V2024-1211 ALPHAMIN RESOURCES CORP.  ("AFM")BULLETIN TYPE:  Declaration of DividendBULLETIN DATE:  April 26, 2024TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend Amount per Common...

at 21:22
Wall Financial Corporation (the "Company") released its operating results and financial statements for the three months and year  ended January 31, 2024.  The Company recorded net earnings and comprehensive income attributable to shareholders of the...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: